SwePub
Sök i LIBRIS databas

  Utökad sökning

WFRF:(Zingone A.)
 

Sökning: WFRF:(Zingone A.) > Screening for celia...

LIBRIS Formathandbok  (Information om MARC21)
FältnamnIndikatorerMetadata
00003962naa a2200517 4500
001oai:DiVA.org:oru-56527
003SwePub
008170317s2015 | |||||||||||000 ||eng|
009oai:prod.swepub.kib.ki.se:131103929
0247 a https://urn.kb.se/resolve?urn=urn:nbn:se:oru:diva-565272 URI
0247 a https://doi.org/10.1177/20506406145616682 DOI
0247 a http://kipublications.ki.se/Default.aspx?queryparsed=id:1311039292 URI
040 a (SwePub)orud (SwePub)ki
041 a engb eng
042 9 SwePub
072 7a ref2 swepub-contenttype
072 7a for2 swepub-publicationtype
1001 a Ludvigsson, Jonas F.u Karolinska Institutet,Region Örebro län,Dept Paediat, Örebro University Hospital, Örebro, Sweden; Dept Med Epidemiol & Biostat, Karolinska Inst, Stockholm, Sweden4 aut0 (Swepub:oru)jsln
2451 0a Screening for celiac disease in the general population and in high-risk groups
264 c 2015-04
264 1b Wiley,c 2015
338 a print2 rdacarrier
520 a Background: Celiac disease (CD) occurs in approximately 1% of the Western population. It is a lifelong disorder that is associated with impaired quality of life (QOL) and an excessive risk of comorbidity and death. Objectives: To review the literature on screening for CD in relation to the current World Health Organization (WHO) criteria for mass screening. Methods: We performed a PubMed search to identify indexed papers on CD screening with a publication date from 1900 until 1 June 2014. When we deemed an abstract relevant, we read the corresponding paper in detail. Results: CD fulfills several WHO criteria for mass screening (high prevalence, available treatment and difficult clinical detection), but it has not yet been established that treatment of asymptomatic CD may reduce the excessive risk of severe complications, leading to higher QOL nor that it is cost-effective. Conclusions: Current evidence is not sufficient to support mass screening for CD, but active case-finding may be appropriate, as we recognize that most patients with CD will still be missed by this strategy. Although proof of benefit is still lacking, screening for CD may be appropriate in high-risk groups.
650 7a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Gastroenterologi0 (SwePub)302132 hsv//swe
650 7a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Gastroenterology and Hepatology0 (SwePub)302132 hsv//eng
653 a Celiac disease
653 a gluten
653 a gluten-free diet
653 a review
653 a screening
653 a prevention
653 a risk
653 a quality of life
653 a World Health Organization
7001 a Card, Timothy R.u Dept Epidemiol & Publ Hlth, Univ Nottingham, Nottingham, England4 aut
7001 a Kaukinen, Katriu Sch Med, Univ Tampere, Tampere, Finland; Dept Internal Med, Tampere Univ Hosp, Tampere, Finland;Dept Internal Med, Seinajoki Cent Hosp, Seinajoki, Finland4 aut
7001 a Bai, Juliou Dept Med, C Bonorino Udaondo Gastroenterol Hosp,Univ Salvador, Buenos Aires DF, Argentina4 aut
7001 a Zingone, Fabianau Dept Med & Surg, Univ Salerno, Salerno, Italy4 aut
7001 a Sanders, David S.u Reg GI & Liver Unit, Royal Hallamshire Hosp, Sheffield, England4 aut
7001 a Murray, Joseph A.u Coll Med, Dept Immunol, Dept Med, Mayo Clin, Rochester MN, USA4 aut
7102 a Region Örebro länb Dept Paediat, Örebro University Hospital, Örebro, Sweden; Dept Med Epidemiol & Biostat, Karolinska Inst, Stockholm, Sweden4 org
7730 t United European Gastroenterology journald : Wileyg 3:2, s. 106-120q 3:2<106-120x 2050-6406x 2050-6414
8564 u https://europepmc.org/articles/pmc4406899?pdf=render
8564 8u https://urn.kb.se/resolve?urn=urn:nbn:se:oru:diva-56527
8564 8u https://doi.org/10.1177/2050640614561668
8564 8u http://kipublications.ki.se/Default.aspx?queryparsed=id:131103929

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy